Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (361-370 of 504) with videos related to

Pageof 51
Sort By:
Neuroimage|February 22, 2026
Interictal Epileptiform Discharges propagation revealed by MEG/foramen ovale-EEG co-recording in patients with temporal lobe epilepsy candidate to neurosurgeryDunja Duran, Giulia Maccanti, Michele Rizzi, et al.
Nature Communications|April 20, 2022
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleationGerard Llimos, Vincent Gardeux, Ute Koch, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Haematologica|May 28, 2017
Mutations in the 3' untranslated region of <i>NOTCH1</i> are associated with low CD20 expression levels chronic lymphocytic leukemiaTamara Bittolo, Federico Pozzo, Riccardo Bomben, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansineAlberto J Arribas, Eugenio Gaudio, Sara Napoli, et al.
Hematological Oncology|December 17, 2009
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomasMarta Scandurra, Davide Rossi, Clara Deambrogi, et al.
International Journal of Molecular Sciences|December 22, 2019
Correction: Sciacca, F. L., et al. Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome. Int. J. Mol. Sci. 2018, 19, 3675Francesca Luisa Sciacca, Ambra Rizzo, Gloria Bedini, et al.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Blood Advances|October 7, 2024
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomasAlberto J Arribas, Sara Napoli, Eugenio Gaudio, et al.
Haematologica|November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiMichele Merli, Carlo Visco, Michele Spina, et al.
Pageof 51

Showing results (361-370 of 504) with videos related to

Sort By:
Pageof 51
Neuroimage|February 22, 2026
Interictal Epileptiform Discharges propagation revealed by MEG/foramen ovale-EEG co-recording in patients with temporal lobe epilepsy candidate to neurosurgeryDunja Duran, Giulia Maccanti, Michele Rizzi, et al.
Nature Communications|April 20, 2022
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleationGerard Llimos, Vincent Gardeux, Ute Koch, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Haematologica|May 28, 2017
Mutations in the 3' untranslated region of <i>NOTCH1</i> are associated with low CD20 expression levels chronic lymphocytic leukemiaTamara Bittolo, Federico Pozzo, Riccardo Bomben, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansineAlberto J Arribas, Eugenio Gaudio, Sara Napoli, et al.
Hematological Oncology|December 17, 2009
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomasMarta Scandurra, Davide Rossi, Clara Deambrogi, et al.
International Journal of Molecular Sciences|December 22, 2019
Correction: Sciacca, F. L., et al. Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome. Int. J. Mol. Sci. 2018, 19, 3675Francesca Luisa Sciacca, Ambra Rizzo, Gloria Bedini, et al.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Blood Advances|October 7, 2024
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomasAlberto J Arribas, Sara Napoli, Eugenio Gaudio, et al.
Haematologica|November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana LinfomiMichele Merli, Carlo Visco, Michele Spina, et al.
Pageof 51